| A |
| A Ganser |
- |
Reproductive Choices, Pregnancies and Deliveries in Carriers of Hemophilia – Results of the CarrierQOL-Study |
| A Viswabandya |
- |
Thirty Novel Mutations in the Factor VIII Gene of Indian Patients with Haemophilia A |
| A Srivastava |
- |
Thirty Novel Mutations in the Factor VIII Gene of Indian Patients with Haemophilia A |
| A Tripodi |
- |
The Detection of Lupus Anticoagulants in Hemophiliacs: The Need for Different Assay Systems |
| A Cipolla |
- |
Proposal of Immunotolerance Induction in Haemophiliacs A with Inhibitors Undergoing to Pressing Elective Surgery by Using FVIII/vWF-enriched Pure Plasmaderivates |
| A Coppola |
- |
Pegylated Interferon and Ribavirin Anti-hepatitis C Therapy in Patients with Hemophilia Is as Effective and Safe as in Non-hemophilic Patients |
| A Rocino |
- |
Pegylated Interferon and Ribavirin Anti-hepatitis C Therapy in Patients with Hemophilia Is as Effective and Safe as in Non-hemophilic Patients |
| A Iorio |
- |
Pegylated Interferon and Ribavirin Anti-hepatitis C Therapy in Patients with Hemophilia Is as Effective and Safe as in Non-hemophilic Patients |
| A Dragani |
- |
Pegylated Interferon and Ribavirin Anti-hepatitis C Therapy in Patients with Hemophilia Is as Effective and Safe as in Non-hemophilic Patients |
| A.R.N.A.S Ospedale Civico, Palermo, Italy |
- |
Assessment of the Thrombophilic Risk in Women Candidates to Hormone Replacement Therapy |
| Aardestrup IV |
- |
Plasma Lipids and Lipoproteins in Healthy Subjects are Closely Related to INR |
| Aaron L |
- |
Evaluation of Stability of Sucrose – Formulated, Full-Length Rfviii for Use in Continuous Infusion Therapy |
| Aarsman CJ |
- |
Activation of the Fibrinolytic System by Amyloid Cross-b Structure Results In reply to: Cell Detachment AND Processing of Neuroendocrine Factors |
| Aaspõllu A |
- |
A Heterodimeric Metalloprotease from Vipera Lebetina Venom Induces Human Endothelial Cell Apoptosis |
| Aballi S |
- |
A Fast Track Strategy for Managing Suspected Pulmonary Embolism (PE) in Outpatients |
| Abashidze A |
- |
Comparative Analysis of Methods for Assessment of Circulating Endothelial Progenitor Cells Indicated Heterogeneity of Subpopulations at Various Stages of Differentiation |
| Abbadessa V |
- |
Successful Treatment of Acquired Haemophilia with FEIBA® and Retuximab® |
| Abbate R |
- |
Antiaggreganting Agents Do Not Influence the Sonoclot Profile |
| |
- |
Managed Hemostasis ‘Point-Of-Care’ Testing in a Large Hospital: A Three-Year Experience and the Assessment of Clotting Tests |
| |
- |
Warfarin Therapy in AF Patients: Females Are Still at Risk |
| |
- |
Protein Z Plasma Levels in Different Phases of Activity of Coronary Atherosclerosis |
| |
- |
Inflammatory Markers are Associated with the Abdominal Aortic Diameter |
| |
- |
Tissue Factor Pathway Inhibitor (TFPI) and Thrombin Activable Fibrinolysis Inhibitor (TAFI) in Juvenile Deep Vein Thrombosis |
| |
- |
Thrombophilia Is Frequent in Superficial Vein Thrombosis and Is Associated with Recurrence: A Retrospective Study |
| |
- |
The Contemporary Presence of Elevated Levels of Factor VIII and PAI-1 Is a Risk Factor for Recurrent Thromboembolism. A Retrospective Case–Control Study |
| |
- |
Interaction of Choline/Betaine Metabolysm and Homocysteine Plasma Levels |
| |
- |
Influence of the Enos Gene Polymorphisms on the Homocysteine Plasma Levels in Healthy Subjects |
| |
- |
ACE DD Genotype: A Predisposing Factor to Abdominal Aortic Aneurysm |
| |
- |
Systemic Sclerosis: Gene Expression Profiling by Microarray Technology of Endothelial Cells |
| |
- |
Prevalence of Inflammatory Gene Polymorphisms in Nonvalvular Atrial Fibrillation Patients |
| |
- |
eNOS Gene Affects Blood Viscosity and Red Cell Deformability: Role of eNOS T-786C, G894T and 4a/4b Polymorphisms |
| |
- |
Semi-Synthetic Sulfaminoheparosans Induce Tissue Factor Pathway Inhibitor Release by Human Umbelical Vein Endothelial Cells (HUVEC) |
| |
- |
Vitamin B6 Serum Level and Inflammation and in the InChianti Study |
| |
- |
Homocysteine, Vitamins and C-reactive Protein in the InCHIANTI Study |
| |
- |
Protein Z Decreases During Follow-up of Patients with Acute Coronary Syndromes |
| |
- |
Inherited and Acquired Thrombophilic Risk Factors in Atherosclerotic Disease |
| Abbate R |
- |
C677T and A1298C MTHFR, A2756G MTR and 844ins68 CBS Gene Polymorphisms in Atrial Fibrillation |
| |
- |
Platelet Function Predicts Myocardial Damage in Patients with Acute Coronary Syndromes Treated with Multiple Antiplatelet Agents |
| Abbate R |
- |
Ischemic Complications in Nonvalvular Atrial Fibrillation Patients Despite Warfarin Therapy |
| |
- |
Clotting Profile by Sonoclot Analysis Is Different in Patients Undergoing Off-Pump and On-Pump Coronary-Artery Bypass Surgery |
| |
- |
High Risk of Recurrence in Renal Transplant Recipients after a First Episode of Venous Thromboembolism |
| |
- |
MTHFR C677T Polymorphism is Associated with Low Levels of Folic Acid in the InChianti Study |
| |
- |
Asymmetric Dimethyl Arginine (ADMA), Homocysteine and Semicarbazide-Sensitive Amine Oxidase Activity (SSAO): New Markers of Oxidative Stress in Acute Coronary Syndromes |
| |
- |
High Rate of Non Responders to Aspirin and/or Clopidogrel Treatment in the First Days Following Percutaneous Coronary Interventions: An Ex Vivo Study |
| |
- |
Polymorphisms in Genes Involved in Homocysteine Metabolism in the INCHIANTI Study |
| |
- |
Combined Oral Anticoagulant and Antiplatelet Therapy And Bleeding Risk |
| |
- |
Thrombophilia in Patients with Spinal Cord Injury |
| Abbühl B |
- |
Immunate S/D – Results of a Phase III, Prospective, Multicenter Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Efficacy of Immunate Solvent Detergent in Previously Treated Patients with Severe or Moderately Severe Hemophilia A |
| Abdalla D |
- |
Soluble VEGF/sFlt-1 Ratio is Independent Predictor of AML Patient Outcome |
| Abdel Gader A |
- |
Tissue Factor Pathway Inhibitor (TFPI) in Childhood Nephrotic Syndrome |
| Abdel Hafez A |
- |
Soluble P-Selectin Levels in Diabetes Mellitus Patients with Coronary Artery Disease |
| Abdelhaleem M |
- |
Detection of Platelet Dense Granule Deficiency in Pediatric Patients by Quantitative Electron Microscopy |
| |
- |
Utility of aPTT in Monitoring Unfractionated Heparin in Children |
| Abdelrahman N |
- |
Dynamic Responsiveness to Aspirin in Patients Undergoing PCI |
| Abdolreza A |
- |
Thromboembolic Disease and Its Relationship with ABO-Rh Blood-Groups and Other Variables in Patients at Warfarin Clinics in Iran |
| Abe Y |
- |
A Simple Technique to Determine Thrombopoiesis Level Using Immature Platelet Fraction (IPF) |
| Abe Y |
- |
High Mobility Group Box Protein Is Increased in the Plasma and May Have a Role in Development of Organ Failure in DIC |
| |
- |
Proteinase 3 Expression on Neutrophil Membranes from Patients with Infectious Disease |
| Abell L |
- |
Evaluation of a Novel Direct Factor VIIa Inhibitor in Rabbit Models of Arterial Thrombosis and Hemostasis |
| Abendschein D |
- |
Inhibition of Thrombosis after Vascular Injury with a Novel Tissue Factor-Targeted Thrombomodulin Fusion Protein |
| Aberbach I |
- |
ProC Global Assay in the Evaluation of Women at Risk for VTE While Using Hormonal Therapy |
| Åberg M |
- |
Tissue Factor Regulation, RhoA Localization, and Induction of Apoptosis in Human Cancer Cell Lines upon Simvastatin Treatment |
| Abeyama K |
- |
Thrombomodulin Binds Lethal Cytokine HMGB1 and Neutralizes Its Pro-inflammatory Activity: Novel Cytoprotective Action of Thrombomodulin |
| |
- |
Endocannabinoid Anandamide Induces High Mobility Group Box 1 (HMGB1) Protein Release in Monocytes and Macrophages |
| Abgrall JF |
- |
Clinical Impact of Screening for Factor V Leiden First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden |
| |
- |
Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden |
| |
- |
Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden: An Analysis According to Age of Patients |
| Abid Hussein MN |
- |
Inhibition of Microparticle Release from Endothelial Cells Induces Apoptosis |
| |
- |
Cell-derived Microparticles Contain Caspase 3 in Vitro and in Vivo |
| Aboelfetoh N |
- |
Elevated Serum Nerve Growth Factor (NGF) Levels in Patients with Acute Leukemia and Lymphoma Especially with CNS Involvement |
| Aboud M |
- |
To Mix with Pooled Normal Plasma or Not to Mix: A Comparative Study of Two Approaches to Assessing Lupus Anticoagulant Inhibitory Activity in the Dilute Russell Viper Venom Method |
| Aboud M |
- |
How Useful is the Monitoring of (Low Molecular Weight) Heparin Therapy by Anti-Xa assay? The Laboratory Perspective |
| |
- |
Towards Harmonisation of D-dimer Assays |
| |
- |
Use of a Functional Assay to Diagnose Protein S Deficiency; Increasing Testing of Obstetric Patients Yields Unreliable Results |
| |
- |
Discrepancies between the Overall Coagulation Potential (OCP) Assay and International Normalised Ratio (INR) in Warfarin-Treated Patients |
| Abrahamsen B |
- |
Occurrence of Venous Thrombosis (VT) Is Not Increased in Women Taking Postmenopausal Hormonal Replacement Therapy (HRT) in the Danish Osteoporosis Prevention Study (DOPS) |
| Abrams Z |
- |
rFVIIa (NovoSeven®) for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients with Inhibitors: A Double-Blind Study of a Single High Dose Versus Standard Multiple Doses of rFVIIa |
| |
- |
Treatment of Glanzmann's Thrombasthenia (GT): A Prospective Observational Registry on the Use of Recombinant Human Activated Factor VII (rFVIIa) and Other Hemostatic Agents |
| Abshire T |
- |
Leukemia after P32 Radionuclide Synovectomy for Hemophilic Arthropathy |
| Abshire TC |
- |
Clinical and Laboratory Features of Mild Bleeding Disorders (MBD) in Children |
| Abu-Ghoush M |
- |
A Thirteen Year Retrospective Study of Inherited Bleeding Disorders in the Jordanian Population |
| Abumiya T |
- |
Tissue Factor Expression in Human Neutrophils |
| Abu-Samra H |
- |
Identification and Characterization of 10 Novel Mutations Causing Factor XI Deficiency |
| Abuzenadah AM |
- |
Prevalence of Genetic Risk Factors Causing Thrombophilia in Normal Population and Recurrent Abortions Patients in Saudi Arabia |
| Accardo PA |
- |
Different Intracytoplasmatic Pattern of BCL-2 Family Proteins in Lymphocytes from Subjects Positive for Antiphospholipid Antibodies (APL) |
| |
- |
Resistance to Activated Proteine C (aPCR) in Subjects ‘Negative’ for Factor V Leiden (FVL) and ‘Positive’ for Antiphospholipid Antibodies (APL) |
| Achen MG |
- |
Molecular Pathways for Lymphangiogenesis and Their Role in Human Disease |
| Achiron A |
- |
Evaluation of Pro-angiogenic and Pro-Coagulant Activity of Irradiated, Non Irradiated and Filtered Stored Blood Used in Transfusion Practice |
| Acosta S |
- |
The Risk of Proximal DVT and Pulmonary Embolism (PE) in Patients with Objectively Verified Arterial Thrombosis. A Population-Based Autopsy Study |
| Adachi H |
- |
Factor VIII Mimetic Antibody: (1) Establishment and Characterization of Anti-factor IX/Anti-factor X Bispecific Antibodies |
| Adachi T |
- |
Targeted Disruption of Mouse Ortholog of the Human MYH9 Responsible for Macrothrombocytopenia with Different Organ Involvement: Hematological, Nephrological, and Otological Studies of Heterozygous KO Mice |
| Adachi E |
- |
Analyses of the Interaction of Platelet Collagen Receptor Glycoprotein (GP) VI with Various Types of Collagen |
| Adachi T |
- |
In vitro Characterization of Two Missense Mutations Associated with Quantitative Protein S Deficiency |
| Adam M |
- |
The Role of Annexin A5 and Anti-Annexin A5 Antibodies in the Antiphospholipid Syndrome |
| Adamczuk Y |
- |
Comparison Among the New Immunoassays with Monoclonal Antibody Calibration and Home-Made Methods for Testing the Antiphospholipid Antibody (APA) Family |
| |
- |
A Lower Calcium Concentration Prolongs More Frequently Dilute Prothrombin Time (dPT) of Patients with Lupus Anticoagulant (LA) and Anti-B2GPI Antibodies (aB2GPI) |
| Adamek L |
- |
Venous Thromboembolism, Arterial Thrombosis and Plasma Homocysteine Levels in Families with Inherited Thrombophilia |
| Adams TE |
- |
Molecular Models of the Prothrombinase Complex |
| Adams M |
- |
Heparin Has Variable Effects on the Release of Glycosylphosphatidylinositol-Lipid Anchored TFPI from Human Umbilical Vein Endothelial Cells |
| Adamson PJ |
- |
Identification of the Region of FXIIIA Responsible for Binding to the Alpha Chain of Fibrin(ogen) |
| Adamtziki E |
- |
Correlation of Various Mutations and Polymorphisms with the Risk of Thrombosis in Children |
| |
- |
Mutations Causing Type 3 Von Willebrand Disease in a Small Cohort of Greek Patients |
| |
- |
Gene Conversions Are a Common Cause of von Willebrand Disease |
| |
- |
Thromboembolic Episodes in Children: 15 years Experience from One Centre |
| Ádány R |
- |
Three Novel Missense Mutations and Their Functional Consequences in Two Severe Inherited Factor X Deficiencies |
| Adcock DM |
- |
A Comparison of Calibration Curves Using Unfractionated Heparin, Enoxaparin, Dalteparin, and Fondaparinux in a Chromogenic Anti-FXa Assay |
| |
- |
Intrinsic Factor Responsiveness of an aPTT Reagent Is Significantly Influenced by the Type of Factor Deficient Plasma Used |
| Adelmeijer J |
- |
Platelet Adhesion to Dimeric Beta2-Glycoprotein-I Under Conditions of Flow Is Mediated by Glycoprotein Iba |
| |
- |
Glycoprotein Iba-Mediated Platelet Adhesion and Aggregation to Immobilized Thrombin under Conditions of Flow |
| |
- |
Highly Elevated Levels of Von Willebrand Factor in Patients with Liver Cirrhosis Support Platelet Adhesion Despite Its Reduced Functional Capacity |
| Adess M |
- |
Circulating Inhibitor in an Elderly Female That Impairs the Action of Human But Not Rabbit Brain Thromboplastin |
| Adraktas, Th, Karafoulidou A |
- |
CoaguChek S Accuracy And Reproducibility in Comparison with the BCS Analyzer: Results in an Outpatient Anticoagulation Clinic |
| Aerts JMFG |
- |
SELDI-TOF MS: A Potential High-Throughput Tool for High-Density Lipoprotein Analysis |
| Afrasiabi AR |
- |
Prothrombin G20210A and Factor V Leiden Mutations in Southern Iran |
| Afuwape A |
- |
Adenovirus-Mediated VEGF Gene Therapy Enhances Venous Thrombus Resolution |
| Agarwal P |
- |
Quality Systems in Automated Plateletpheresis in Hospital Based Blood Transfusion Services in North India |
| Ageenkova EV |
- |
Ulcerous Colitis in Children with Hemophilia A |
| Ageno W |
- |
Prevalence of Thrombophilic Abnormalities in Patients with Deep Vein Thrombosis or Pulmonary Embolism |
| Ageno W |
- |
Incidence of Deep Vein Thrombosis Following Gynecologic Laparoscopy: A Prospective Cohort Study |
| Ageno W |
- |
Abdominal Obesity and the Risk of Recurrent Deep Vein Thrombosis |
| Ageno W |
- |
D-Dimer Measurement after Acute Ischemic Stroke Does Not Predict Long Term Outcome Events |
| Ageno W |
- |
A Randomized Trial Comparing 1 mg Oral Vitamin K with Placebo for the Treatment of Warfarin-associated Coagulopathy in Patients with Mechanical Heart Valves |
| |
- |
D-Dimer and the Risk of Venous Thromboembolism in Medical Patients |
| |
- |
The Risk of Venous and Arterial Thrombosis in Patients with HIV Infection |
| |
- |
Clinical Experience with Optional Vena Cava Filters: Results of a Prospective Observational Multicenter Study |
| |
- |
A Prospective Registry on the Long-Term Clinical Outcome of Venous Thromboembolism (Multicenter Advanced Study for a ThromboEmbolism Registry – MASTER): Description of the study cohort |
| Ageno W |
- |
Prevalence of the Metabolic Syndrome in Patients with Provoked or Unprovoked Deep Vein Thrombosis and in Controls |
| Ageno W |
- |
Duration of Anticoagulant Treatment and Recurrence of Venous Thromboembolism in Patients with and without Thrombophilia |
| |
- |
Risk Factors for CVC-Associated Thrombosis in Cancer Patients: Analysis of the ETHIC Study |
| Aggarwal A |
- |
Transendocardial Autologous Bone Marrow Cell Transplantation in Patients with Advanced Ischemic Heart Disease – A Multi-Center Feasibility Study |
| Aggarwal MA |
- |
Reduction of Ex Vivo Thrombus Evolution with Anti-Platelet Therapy during Percutaneous Coronary Intervention: The REVEAL Study |
| Aggio M |
- |
Prothrombotic Risk Factors of Fabry Patients in Argentina |
| Agnelli G |
- |
Duration of Anticoagulant Treatment and Recurrence of Venous Thromboembolism in Patients with and without Thrombophilia |
| |
- |
ASA and NSAIDs with Melagatran/Ximelagatran or Enoxaparin Do NOT Increase Bleeding in Patients Undergoing Joint Replacement Surgery. The METHRO III Study |
| Agnelli G |
- |
A Prospective Registry on the Long-Term Clinical Outcome of Venous Thromboembolism (Multicenter Advanced Study for a ThromboEmbolism Registry – MASTER): Description of the study cohort |
| Agnelli G |
- |
Postoperative Pulmonary Embolism Detected by Multi-slice Computerized Tomography (MSCT) after Lung Surgery FcOR Cancer |
| Agnelli G |
- |
Effect of Blood Salvage and Re-infusion on VTE Complications in Patients Undergoing Elective Major Orthopedic Surgery |
| Agnelli G |
- |
The Efficacy and Safety of Thromboprophylaxis after Acute Ischemic Stroke: What Agent and Which Dose? |
| Agnelli G |
- |
Bleeding Events with Lytics and Thienopyridines in Patients with ST-Segment Elevation Myocardial Infarction. The Global Registry of Acute Coronary Events |
| Agnelli G |
- |
Risk Factors for VTE In Patients Undergoing Abdominal Surgery: Lessons from the PEGASUS Trial |
| |
- |
High Incidence of Bilateral Deep Vein Thrombosis in Cancer Patients |
| |
- |
Prevalence of Thrombophilic Abnormalities in Patients with Deep Vein Thrombosis or Pulmonary Embolism |
| |
- |
Low-Dose Aspirin for Secondary Prophylaxis of Vein Thrombosis – A Prospectively Planned Meta-Analysis |
| Agnelli G |
- |
Risk Factors for CVC-Associated Thrombosis in Cancer Patients: Analysis of the ETHIC Study |
| Agnes R |
- |
Any Relationship Between Inherited Thrombophilia and Bleeding Phenotype or Vascular Disease in Patients with Hemophilia and von Willebrand Disease? |
| Agneta S |
- |
Interleukin-18 Predicts Long-term Mortality in Patients with Non-ST Elevation Acute Coronary Syndrome |
| Agostoni P |
- |
Impaired Bradykinin Response to Ischemia and Exercise in Patients with Mild Congestive Heart Failure During Angiotensin-Converting Enzyme Treatment. Relationships with Endothelial Function, Coagulation and Inflammation |
| Ågren A |
- |
Prospective Evaluation of Low PAI-1 Activity as a Risk Factor for Hemorrhagic Diathesis |
| Aguilar F |
- |
An Early-Activated Gene (6A3-5) Implicated in the Control of Vascular Smooth Muscle Cell Functions |
| Aguzzi A |
- |
Removal of PrPSc in the Manufacturing Process of OCTAPLAS and UNIPLAS |
| AHCDC |
- |
Understanding the Genotype/Phenotype Link in Type 1 von Willebrand Disease (VWD): Results from The Canadian Type 1 VWD Study |
| Ahlenc-Gelas M |
- |
Interactions between Prothrombotic Mutations and Hormone Therapy in Relation to the Risk of Venous Thromboembolism: Impact of the Route of Estrogen Administration |
| Ahlgren A |
- |
A Normal D-dimer and a Low Clinical Probability Test Safely Excludes Venous Thromboembolism. A Follow-up D-dimer Adds No Further Information |
| Ahluwalia J |
- |
Prevalence of Risk Factors for Venous Thromboembolism: A Study from North India |
| Ahmad S |
- |
Heparin-Platelet Factor 4 Antibodies are Common among Recently Hospitalized Patients with Acute Coronary Syndromes Presenting to the Emergency Department |
| Ahmad SS |
- |
The Assembly of the Factor-X Activating Complex on Activated Platelets is Down-regulated by the Formation of Lipid Rafts that Remove the Substrate (Factor X) and the Cofactor (Factor VIIIa) from the Enzyme (Factor IXa) |
| Ahmad S |
- |
CD40 and CD40 Ligand (CD40L) in Primary Hemostasis and Antibody-Mediated Platelet Activation |
| Ahmad F |
- |
FcgRIIa Platelet Polymorphism in Asian Indians: Its Association with Development of Heparin Induced Thrombocytopenia |
| Ahmad S |
- |
FcgRIIa Platelet Polymorphism in Asian Indians: Its Association with Development of Heparin Induced Thrombocytopenia |
| Ahmad S |
- |
Importance of Pre-Analytical Variables in the Measurement of Platelet-Derived Microparticles |
| |
- |
Cellular Effects of Heparin-PF4 Antibodies and Its Relevance to the Pathogenesis of Heparin-Induced Thrombocytopenia |
| Ahn Y |
- |
Interstitial Pulmonary Lesions in Patients with Recurring Severe ITP |
| Ahn E |
- |
Interstitial Pulmonary Lesions in Patients with Recurring Severe ITP |
| |
- |
ITP Developing in Spouses of Patients with Chronic ITP: ‘Spousal ITP’ |
| Ahn Y |
- |
ITP Developing in Spouses of Patients with Chronic ITP: ‘Spousal ITP’ |
| Ahn E |
- |
Antiphospholipid Antibodies and Platelet Activation as Thrombotic Risk Factors in Thrombocythemia Associated with Myeloproliferative Disorder |
| Ahn Y |
- |
Antiphospholipid Antibodies and Platelet Activation as Thrombotic Risk Factors in Thrombocythemia Associated with Myeloproliferative Disorder |
| Ahn H |
- |
Antithrombotic Effects of SCH 205831: A Potent, Selective and Orally Active Antagonist of the PAR-1 Thrombin Receptor |
| Ahn E |
- |
Endothelial Microparticle Binding to Neutrophils Is an Important Determinant of Neutrophil Activation In Vivo in Different Clinical Conditions |
| Ahn YS |
- |
Endothelial Microparticle Binding to Neutrophils Is an Important Determinant of Neutrophil Activation In Vivo in Different Clinical Conditions |
| Ahn JY |
- |
Thymidylate Synthase: A Possible Independent Risk Factor for Silent Brain Infarction |
| Ahnadi CE |
- |
Marginal Effect of Interference of Simvastatin on Clopidogrel Antiplatelet Effectiveness Assessed by Measures of Platelet Activation and Aggregation |
| Ahrens I |
- |
Targeting of the Direct FXa Inhibitor TAP via the Fusion of a Single-chain Antibody Directed Against a LIBS Epitope on GPIIb/IIIa Provides Effective Anticoagulation without Bleeding Time Prolongation |
| Ahrens IG |
- |
Selenium Causes Decreased Rolling and Adhesion of Monocytes under Venous Flow Conditions Via Shedding of L-Selectin (CD62L) |
| Ahrens I |
- |
Polymorphisms Known to Increase the Risk of Atherothrombosis Do Not Affect the Risk of Thrombembolism as Determined in Patients with Atrial Fibrillation |
| Ai J |
- |
The Proximal C-terminal Domains of ADAMTS13 Determine the Recognition and Cleavage of Peptidyl Substrate VWF73 and Macromolecular Substrate von Willebrand Factor |
| |
- |
Apical Sorting of ADAMTS13 in Madin-Darby Canine Kidney (MDCK) Cells Depends on an Association with Detergent-Insoluble Sphingolipid and Cholesterol-Enriched Rafts |
| Aiach M |
- |
The TM -1208/-1209delTT Gene Promoter Polymorphism and Circulating Monocyte Thrombomodulin (TM) Gene Expression in 100 Healthy Volunteers |
| |
- |
Elevated Gas6 Plasma Levels in Patients with Severe Sepsis |
| |
- |
Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions |
| Aillaud MF |
- |
Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects |
| Aiosa A |
- |
Idiopathic Acquired Haemophilia: Two Case Reports with Different Severity of Clinical Manifestation, Both in Rapid Disappearing with Non-Aggressive Immunotherapy |
| |
- |
Assessment of Protein S on Hepatopaths at the Last Stage |
| |
- |
Assessment of the Thrombophilic Risk in Women Candidates to Hormone Replacement Therapy |
| Aird WC |
- |
Isolation and Characterization of Human Bone-Derived Endothelial Cells (hBDECs) for the Study of Vascular Bone Disease States |
| Aisina RB |
- |
Activation Kinetics of Glycoform of GLU-Plasminogen and Lys-Plasminogen by Plasmin-Staphylokinase Complex |
| |
- |
Inhibition Kinetics of Plasmin-staphylokinase (Pm-STA) and Plasmin-Streptokinase (Pm-SK) Complexes with Different Protein Inhibitors |
| |
- |
Fibrin-Monomer Prepared Using Thrombin-Like Enzyme from Snake Venom Agkistrodon Halys as Stimulator of Plasminogen Activation By t-PA |
| Aiso S |
- |
Platelet aIIbb3 Integrin Constrained in the Extended Conformer Represents an Highly Activated Form |
| Aito S |
- |
Thrombophilia in Patients with Spinal Cord Injury |
| Aixalá M |
- |
Hyperhomocysteinemia, Anticardiolipin Antibodies, and Risk for Vascular Access Thrombosis in Hemodialysis Patients |
| Aizawa K |
- |
Significance of the Transcription Factor KLF5 in Cardiovascular Remodeling |
| Ajzenberg N |
- |
Enhanced Shear-Induced Platelet Aggregation in Patients Who Experienced Subacute Stent Thrombosis: A Case-Control Study |
| Ajzner E |
- |
Severe Acquired Factor XIII Deficiency Caused by an Autoantibody against the B Subunit |
| Ajzner É |
- |
Three Novel Missense Mutations and Their Functional Consequences in Two Severe Inherited Factor X Deficiencies |
| AjznerMéhes ÉL |
- |
Acquired FXIII Deficiency in a Patient with Systemic Lupus Erythematodes: Clinical Presentation and Management |
| Akakura N |
- |
Cobra Cardiotoxins, Members of the Ly-6 Protein Family, Specifically Bind to Integrin alphavbeta3 |
| Akbar H |
- |
Gene Targeting or Pharmacological Inhibition of Rac GTPases Prolongs the Bleeding Time and Reduces Platelet Adhesion, Secretion and Aggregation: Evidence for the Rac-Mediated Activation of MAP Kinases during Platelet Activation |
| Akbulut A |
- |
Retrospective Open Multicenter Study on the Efficacy and Safety of Activated Prothrombin Complex (Feiba®) in Haemorrhage and Surgical Interventions in Haemophilia Patients with Inhibitor and in Patients with Rare Bleeding Disorders in Turkey |
| Akhavan S |
- |
Perturbation of pKa Values of Catalytic Residues in the NATURAL Thrombin: Mutant with Deletion of Lys9 in The A-Chain |
| |
- |
Factor X Gene Mutations Affecting the Gla Domain of the Protein |
| Akinwunmi F |
- |
Satisfaction and Safety of Two Domiciliary Anticoagulation Services for Mobility-impaired Patients: Preliminary Trial Findings |
| Akira Y |
- |
Neonatal Gene Therapy with Lentiviral Vector in Murine Hemophilia a Results in Successful Immune Tolerance Induction to Canine Factor VIII |
| Akkerman JWN |
- |
Platelet Activation by Oxidized Low-Density Lipoprotein Is Mediated by CD36 and Scavenger Receptor-A |
| |
- |
Metabolic Arrest Suppresses Platelet Binding to and Phagocytosis by Macrophages |
| |
- |
Adhesive Surface Determines Raft Composition in Platelets Adhering Under Flow |
| |
- |
Impaired Insulin Signaling in Platelets from Patients with Diabetes Mellitus Type 2 |
| |
- |
Glucose Uptake Via GLUT3 in Human Platelets Is Regulated Via PKB |
| |
- |
Down-regulation of Low-Density Lipoprotein-induced Platelet Signaling |
| |
- |
Inhibition of Collagen-Induced Thrombus Formation by Insulin Is Absent in Diabetes Mellitus Type 2 |
| |
- |
Plasma Ecto-NTPDase Prevents Platelet P2X1 and P2Y12 Receptor Desensitization During Storage |
| Aksoy H |
- |
The Role of Gamma-Glutamyltransferase Activity on Early Platelet Apoptotic Process |
| Aktas B |
- |
Platelets in Atherothrombosis: Lessons from Mouse Models |
| Akulich N |
- |
Activation of Fibrinolysis System at the Main Arterial and Venous Vessels Thrombosis with the Treatment of Gene-Engineering Thrombolythic Drug ‘Triasa’ |
| Al Abri QN |
- |
Clinical Profile of Glanzmann's Thrombasthenia from the Sultanate of Oman |
| Al Askalany H |
- |
Soluble VEGF/sFlt-1 Ratio is Independent Predictor of AML Patient Outcome |
| Al Dieri R |
- |
The Relation Between in vitro Thrombin Generation and Signs of in vivo Thrombin Generation; Influence of Pro- and Anti-coagulant Plasma Factors |
| |
- |
Rofecoxib (Vioxx) Increases Thrombin Generation in Platelet Rich Plasma |
| |
- |
The Effect of SC Injection of Heparins of Different Molecular Weight on Thrombin Generation – Consequences for the Question of Monitoring Heparin Treatment |
| |
- |
The Use of Calibrated Automated Thrombin Generation to Detect Alterations of the Clotting System Brought About by Hormone Administration in Pre- and Postmenopausal Women |
| |
- |
The Thrombogram in Twins, Influence of Oral Contraceptive and Intercurrent Infection |
| Al Haddabi H |
- |
Clinical Profile of Glanzmann's Thrombasthenia from the Sultanate of Oman |
| Al Hajzen A |
- |
Low Molecular Weight Fucoidan Is More Effective Than Low Molecular Weight Heparin in Preventing Arterial Thrombosis in a Rabbit Model |
| Al Kindi S |
- |
Clinical Profile of Glanzmann's Thrombasthenia from the Sultanate of Oman |
| |
- |
Unusual Thrombophilic Manifestations of Protein C Deficiency, Factor V Leiden and Antiphospholipid Syndrome From Sultanate of Oman |
| Al Lamki N |
- |
Unusual Thrombophilic Manifestations of Protein C Deficiency, Factor V Leiden and Antiphospholipid Syndrome From Sultanate of Oman |
| Al Lamki Z |
- |
Clinical Profile of Glanzmann's Thrombasthenia from the Sultanate of Oman |
| Al Maarof M |
- |
Unusual Thrombophilic Manifestations of Protein C Deficiency, Factor V Leiden and Antiphospholipid Syndrome From Sultanate of Oman |
| AL1 |
- |
Increased Platelet Activation in Cystic Fibrosis: A Role for cAMP/Adenylate Cyclase But Not for Mead Acid or Platelet CFTR |
| Ala F |
- |
High Sensitivity of Monochloroacetic Acid 1% Clot Lysis Test for Diagnosis of Severe FXIII Deficiency |
| Ala FA |
- |
Mutation Analysis of the Factor VIII Gene in 224 Iranian Families with Haemophilia A |
| Aladle D |
- |
Divergent Patterns of Vascular Endothelial Growth Factor (VEGF) in Patients with Acute Leukemia |
| Alatri A |
- |
A Telemedicine Project for Managing Patients on Oral Anticoagulant Therapy |
| Alaveras M |
- |
Application of Filtration Technologies for Prion Removal from Plasma Product Intermediates |
| Alban S |
- |
The Effect of SC Injection of Heparins of Different Molecular Weight on Thrombin Generation – Consequences for the Question of Monitoring Heparin Treatment |
| Alban S |
- |
Carbohydrate-Based P-Selectin Antagonists: In vitro- and In Vivo Investigations of Structure-Activity Relationships |
| |
- |
Chemically Distinct Anticoagulants Exert Differential Effects on Experimental Melanoma Metastasis |
| Albanèse J |
- |
Different Patterns of Release of the Soluble Form of the Endothelial Protein C Receptor in Critically Ill Patients |
| Alberca I |
- |
Clearance of Latent and Polymeric Antithrombin. Are These Conformational Variants Prothrombotic? |
| Alberio L |
- |
Differential Impact of Selective Serotonin Reuptake Inhibitors on Platelet Activation |
| |
- |
ADAMTS13 Is Present in Human Platelets and Strongly Expressed on COAT-Platelets |
| |
- |
Effects of Temperature and Shear on COAT-Platelets Generation |
| |
- |
Variation in Coagulation Inhibitors During Prolonged Sitting: Possible Pathogenetic Mechanisms for Travel-associated Thrombosis |
| |
- |
Role of GPIb, GPIIb/IIIa and Shear on COAT-Platelets Formation |
| |
- |
Thrombotic Thrombocytopenic Purpura |
| Albert T |
- |
Comparison of B-Cell Epitope and Mutation Type in Haemophilia A Patients |
| Albert LM |
- |
A Monoclonal Antibody to High Molecular Weight Kininogen Reduces Inflammation in the HLA-B27 Transgenic Rat Model of Inflammatory Bowel Disease and Arthritis |
| Albert T |
- |
In Silico Design and in Vitro Validation of a Mimotope for Blocking a FVIII-inhibitor Antibody ESH8 |
| Albert FW |
- |
High Inter-Device Variation of the PFA-100™ Platelet Function Analyzer |
| Albertazzi L |
- |
Different Intracytoplasmatic Pattern of BCL-2 Family Proteins in Lymphocytes from Subjects Positive for Antiphospholipid Antibodies (APL) |
| |
- |
Resistance to Activated Proteine C (aPCR) in Subjects ‘Negative’ for Factor V Leiden (FVL) and ‘Positive’ for Antiphospholipid Antibodies (APL) |
| Albertini P |
- |
Inherited Bleeding Disorders: The Emilia-Romagna Region Register, 2004 Update |
| Alberto MF |
- |
Comparative Effects of Nitroxil (HNO) and NO on Platelet Function and Tyrosine Phosphorilation Pattern of Activated Human Platelets |
| |
- |
Hyperhomocysteinemia, Anticardiolipin Antibodies, and Risk for Vascular Access Thrombosis in Hemodialysis Patients |
| |
- |
Behaviour of the Two-Step Coagulation Assay to Identify Antib2-glycoprotein I (ab2GPI)-Lupus Anticoagulant (LA) in Patients with Antiphospholipid Antibodies |
| Albertson T |
- |
Low Dose (<60 mcg/kg) Recombinant Factor VIIa in Trauma or Coagulopathy |
| Albinni S |
- |
Diagnosis of Central Venous Line-Related Thrombotic Events in the Upper Venous System in Children: Combination of Venography, Venous Ultrasound, and Echocardiography |
| Albisetti M |
- |
Congenital Prothrombotic Disorders in Children with Venous and Arterial Thrombosis |
| |
- |
Complete Thrombolysis of Bilateral Pulmonary Embolism by Two-Sided Catheter-Directed Low-Dose Infusion of Tissue Plasminogen Activator |
| Albisinni R |
- |
Recurrent Arterial Thrombosis in Patients Taking Aspirin |
| |
- |
Clinical and Pharmacoeconomic Impact of Secondary Prophylaxis in Young-Adults with Severe Hemophilia A |
| |
- |
Assessing Efficacy and Safety of Recombinant Activated Factor VII in Patients with Platelet Functional Abnormalities Undergoing Surgical Procedures |
| Albrecht C |
- |
Reduced Expression of ABCA1 and A Novel Missense Mutation That Results in Altered Protein Trafficking Underlie Scott Syndrome |
| Al-Buhairan A |
- |
In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study |
| Alcalay A |
- |
Venous Thromboembolism in 68 142 Patients with Colorectal Cancer |
| Alcaraz MS |
- |
Non-enzymatic Glycation of Antithrombin: Implications in Diabetes Mellitus |
| Alcindor T |
- |
The Whole Blood Platelets Aggregation Test for HIT Diagnosis |
| Alecrim MCG |
- |
Hemostatic Changes in Patients with Malaria |
| Aledort LM |
- |
Surgical Procedures in Patients with Inhibitors to Factor VIII: A Case Series |
| |
- |
Post-marketing Surveillance of Thrombotic Events Among Users of rFVIIa and FEIBA: How Costly Are These Adverse Events? |
| Aledort L |
- |
An Open-Label Study Evaluating the Safety and Efficacy of Long-Term Dosing of AMG 531 in Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura |
| Alentorn F |
- |
Monitoring Different Hemostasis Reactions (Chronometric, Chromogenic and Immunoturbidimetric), Using CCD Technology Based Sensor |
| Alessandrello LA |
- |
Tissue Factor Pathway Inhibitor (TFPI) and Thrombin Activable Fibrinolysis Inhibitor (TAFI) in Juvenile Deep Vein Thrombosis |
| Alessandrello Liotta A |
- |
Homocysteine, Vitamins and C-reactive Protein in the InCHIANTI Study |
| |
- |
Combined Oral Anticoagulant and Antiplatelet Therapy And Bleeding Risk |
| |
- |
Thrombophilia in Patients with Spinal Cord Injury |
| Alessandrello, Liotta A |
- |
MTHFR C677T Polymorphism is Associated with Low Levels of Folic Acid in the InChianti Study |
| Alessandro G |
- |
Inhibitor Development in Previously Untreated or Minimally Treated Patients with Hemophilia a Treated with a Plasma-derived Solvent-detergent Factor VIII Concentrate |
| Alessi MC |
- |
Lipopolysaccharide-Induced Endotoxemia in the Mouse is Aggravated by PAI-1 Overexpression |
| Alessi MC |
- |
Anti-Protein S and Anti-Phosphatidylethanolamine (aPE) Antibodies in Patients with Clinical Features of Antiphospholipid Syndrome (APS) |
| |
- |
Low Platelet Response to Clopidogrel Increased the Risk of Recurrent Atherothrombotic Events in Patients with Non-ST Acute Coronary Syndrome after Coronary Stenting |
| |
- |
TAFI Gene Polymorphisms and Plasma TAFI Levels: A Trans-Ethnic Association Study |
| Alessi MC |
- |
Polymorphism A36G of the Tumor Necrosis Factor Receptor 1 Gene Is Associated with HDL Cholesterol, TNFR1 and PAI-1 Levels in Obese Women |
| Alessi MC |
- |
Role of the Fibrinolytic System in the Development of Obesity and the Metabolic Syndrome |
| Aletti G |
- |
Genetic Study of von Willebrand Factor in Twenty-two Members of an Argentinian Family |
| Alewaeters A |
- |
New Mutation Inducing a von Willebrand 2A Disease |
| Alexander S |
- |
Tissue Factor Targeted Thrombomodulin (Ab(TF)-TM) – a Novel Tissue Factor Neutralizing Antibody Fused to Thrombomodulin (TM) |
| Alexander WS |
- |
Molecular Dissection of Platelet Production Via Random Mutagenesis |
| Alexandre MA |
- |
Hemostatic Changes in Patients with Malaria |
| Alfaro G |
- |
Circulating Platelet-Derived Microparticles in Systemic Lupus Erythematosus: Association with Increased Thrombin Generation and Procoagulant State |
| Alguel G |
- |
Favourable Pregnancy Outcome in Women with a History of Venous Thromboembolism and Prophylactic Low Molecular Weight Heparin (LMWH) |
| Alhaq A |
- |
Absence of Exon V Deleted Factor XI mRNA in Homozygous Factor XI Deficiency |
| Alhenc Gelas M |
- |
The Use of Calibrated Automated Thrombin Generation to Detect Alterations of the Clotting System Brought About by Hormone Administration in Pre- and Postmenopausal Women |
| |
- |
The Relation Between in vitro Thrombin Generation and Signs of in vivo Thrombin Generation; Influence of Pro- and Anti-coagulant Plasma Factors |
| Alhenc-Gelas M |
- |
The TM -1208/-1209delTT Gene Promoter Polymorphism and Circulating Monocyte Thrombomodulin (TM) Gene Expression in 100 Healthy Volunteers |
| Ali S |
- |
The Use of Cow-Brain Tissue as an Alternative Source of Tissue Thromboplastin for Prothrombin Time Tests |
| Alieva EI |
- |
Ulcerous Colitis in Children with Hemophilia A |
| Alikhan R |
- |
Thromboprophylaxis in Medical Patients with an Acute Medical Illness (Excluding Stroke and Myocardial Infarction): A Meta-analysis |
| Alisievitch S |
- |
Effect of Stress on Total Plasma Homocystein Concentration in Rats |
| Alitalo K |
- |
Molecular Pathways for Lymphangiogenesis and Their Role in Human Disease |
| Aliyeva-Karayeva N |
- |
The Use of Laserotherapy in Elderly Patients with Unstable Angina |
| Alizade I |
- |
The Use of Laserotherapy in Elderly Patients with Unstable Angina |
| Alizadeh H |
- |
The Hemostatic State in Cancer Patients: The Relationship Between Hypercoagulable Markers and Cancer Prognostic Markers |
| Aljamali MN |
- |
Hemostatic Effects of Long-Term Expression of Activated Murine FVII in Normal and Hemophilic Mice |
| Allaouchiche B |
- |
Usefulness of Thromboelastography (ROTEM®) in Coagulation Management in Trauma Patient |
| Allard DA |
- |
Apoptotic Mechanisms Underlying High-Risk Plaque |
| Allegrone J |
- |
Early Use of Low-Molecular-Weight or Unfractionated Heparin in Patients with Non-ST-Segment Elevation Myocardial Infarction and Unstable Angina. The Global Registry of Acute Coronary Events |
| Allemand E |
- |
Prevalence of Helicobater Pylori Infection and Clinical Response to Eradication Therapy in Patients Wwith Immune Thrombocytopenic Purpura (ITP) |
| Allen D |
- |
Shear-Induced Platelet Apoptosis |
| Allen G |
- |
Pharmacokinetics of TGN 255, a Novel Intravenous Low Molecular Weight Direct Thrombin Inhibitor, in Healthy Volunteers |
| Allen D |
- |
Regulation of in vivo Viability of Stored Platelet Concentrates by Platelet P-selectin Exposure and Glycoprotein Ib-alpha Downmodulation |
| Allen G |
- |
Pharmacokinetics and Pharmacodynamics of TGN 255, A Novel Intravenous Direct Thrombin Inhibitor in Healthy Volunteers. Comparison with Unfractionated Heparin |
| |
- |
Pharmacokinetics and Pharmacodynamics of TGN 167, a Novel Oral Direct Thrombin Inhibitor in Healthy Volunteers |
| Allen G |
- |
Characterization of a Novel Recombinant Factor VIIa Analog in a Cell-Based Model of Coagulation |
| Allen DL |
- |
There Is No Correlation between HPA-1a Antibody Concentration and Clinical Severity of Neonatal Thrombocytopenia in 200 Pregnancies with HPA Alloimmunisation |
| Alliaume N |
- |
Immune Tolerance with FEIBA in a Severe Haemophiliac B with Inhibitor |
| Almaas V |
- |
A Fast Track Strategy for Managing Suspected Pulmonary Embolism (PE) in Outpatients |
| Almasy L |
- |
A Genome Search for Genetic Determinants That Influence Plasma Fibrinogen Levels |
| |
- |
Effect of F7 Gene Promoter Polymorphisms on Factor VII Antigenic Levels |
| Al-Mazedi M |
- |
Following Cardiac Surgery Patients Who Develop Biphasic Waveforms as Seen on the MDA-180 Automated Coagulation Analyser Have Increased Thrombin Potential in-vitro. This Is Partly due to Tissue Factor Present in the CRP-VLDL Complex |
| Al-Mondhiry HA |
- |
The Fibrinogen Aa R16C Mutation Results in Fibrinolytic Resistance |
| Almonte T |
- |
Comparing Bleed Frequency and Factor Concentrate Use Between Haemophilia A and Haemophilia B |
| |
- |
A System to Track Coagulation Factor Concentrates Can Decrease Waste |
| |
- |
Telephone Consultation Provided by the Hemophilia Treatment Centre – A Significant Part of the Service |
| AL-Mugeirin M |
- |
Tissue Factor Pathway Inhibitor (TFPI) in Childhood Nephrotic Syndrome |
| Almus-Jacobs F |
- |
Role of the Platelet P2Y1 Receptor in Thrombus Formation Under Flow Conditions |
| Al-Mutairi M |
- |
Role of Periodontal Pathogens in Coronary Artery Disease in Saudis |
| Alonso B |
- |
Relation Between Plasmatic Levels of Plasminogen Activator Inhibitor-1 (PAI-1) and Body and Liver Fat Content |
| Al-Rasheed S |
- |
Tissue Factor Pathway Inhibitor (TFPI) in Childhood Nephrotic Syndrome |
| Al-Salloum A |
- |
Tissue Factor Pathway Inhibitor (TFPI) in Childhood Nephrotic Syndrome |
| Alsbjørn B |
- |
FVIIa Decreases Surgery-Induced IL-6 Response in Burn Patients Undergoing Excision and Skin Grafting |
| Al-Tajer S |
- |
The Hemostatic State in Cancer Patients: The Relationship Between Hypercoagulable Markers and Cancer Prognostic Markers |
| Altavilla E |
- |
Should Asymptomatic Children with Hereditary Haemorrhagic Telangiectasia (HHT) Be Screened for Vascular Malformations? |
| Altenburg J |
- |
Decreased Protein C Activation and Accelerated Thrombosis in Human Thrombomodulin Knockin Mice |
| Altinbas M |
- |
Thrombosis in Cancer Patients |
| Altomare M |
- |
Hemostatic Alterations in Pediatric Leukemias |
| Altomare C |
- |
Perturbation of pKa Values of Catalytic Residues in the NATURAL Thrombin: Mutant with Deletion of Lys9 in The A-Chain |
| Altomonte F |
- |
Determinants of Mortality in Cerebral Hemorrhage Patients on Antithrombotic Treatment: Prospective Evaluation in the Italian Emergency Departments of a Multicentric Cohort of 1071 Patients |
| Altomonte M |
- |
Determinants of Mortality in Cerebral Hemorrhage Patients on Antithrombotic Treatment: Prospective Evaluation in the Italian Emergency Departments of a Multicentric Cohort of 1071 Patients |
| Altuntas F |
- |
Lack of Correlation between OD Value of Elisa and Clinical Thrombosis in Patients with Heparin Induced Thrombocytopenia (HIT) |
| Alvarez L |
- |
Thrombophilia in a Healthy Population from Northwest Colombia |
| |
- |
The First Homozygous Family for Factor II G20210A Mutation in Latin America |
| Alvim TC |
- |
Impact of the First Trimester of Hormone Replacement Therapy on the Levels of Hypercoagulability Markers |
| Amagai N |
- |
Circadian Clock Genes are Involved in the Regulation of fibrinolytic Activities in Mice |
| Amand R |
- |
Using a Cohort Model to Anticipate the Future Therapeutic Needs of the Hemophilia A Patient Population |
| Amano K |
- |
Standardization of Assays for Plasma Fibrin-Fibrinogen Degradation Products |
| |
- |
Factor V Mutations, Arg2174Leu, a 5-bp Deletion and Val1813Met, Are Associated with Factor V Deficiency and A Bleeding Tendency |
| Amano M |
- |
Pulmonary Thromboembolism in Cancer Patients Autopsied in a Japanese General Hospital |
| Amant C |
- |
Strong Antithrombotic Effect of the Type III Collagen-Related Octapeptide (KOGEOGPK) in the Mouse |
| Amaral MM |
- |
Ultralarge Multimers of Von Willebrand Factor (VWF) And ADAMTS13 Activity In Plasma From BALB/C And C57Bl/6J Mice At Physiological Conditions |
| Amaral A |
- |
Premature Atherosclerosis in HIV Positive Patients and Cumulated Time of Exposure to Antiretroviral Therapy (SHIVA Study) |
| Amaral M |
- |
Partial Purification of ADAMTS-13 |
| |
- |
Determination of ADAMTS-13 Activity in 13 Patients with Ischemic Stroke |
| Amaral RQ |
- |
Anticardiolipin Antibodies (ACL), Factor V Leiden (FVL) and G20210A Prothrombin Mutation (G20210AII) Do Not Predispose Renal Transplant Recipients to Thrombotic Complications or Graft Loss |
| Amaral M |
- |
Von Willebrand Factor and ADAMTS-13 in 23 Doberman Pinschers Dogs |
| Amarillo H |
- |
Fibrinolytic Peritoneal Response to Laparoscopic Surgery |
| Amato G |
- |
Assessment of Protein S on Hepatopaths at the Last Stage |
| |
- |
Assessment of the Thrombophilic Risk in Women Candidates to Hormone Replacement Therapy |
| Amaya M |
- |
Platelet Microparticles (PMP) Are Increased in Patients with Localized Prostate Cancer and Correlate with Plasma Tissue Factor (TF) Antigen Levels |
| Amaya A |
- |
Cellular Effects of Heparin-PF4 Antibodies and Its Relevance to the Pathogenesis of Heparin-Induced Thrombocytopenia |
| Amaya M |
- |
Importance of Pre-Analytical Variables in the Measurement of Platelet-Derived Microparticles |
| |
- |
CD40 and CD40 Ligand (CD40L) in Primary Hemostasis and Antibody-Mediated Platelet Activation |
| |
- |
Genetic Evidence that CD154 (CD40 Ligand) Plays a Pathophysiologic Role in the Systemic Coagulopathy Associated with Murine Models of Experimental Metastasis and Endotoxemia |
| Amblo J |
- |
Quantitation of FVIII Antigen in Human Plasma |
| Ambo H |
- |
Hepatocytes are the Major Site of ADAMTS-13 Expression in Human Liver |
| Ambrosi P |
- |
Circulating Endothelial Cell Count as a Diagnostic Marker for Non-ST Elevation Acute Coronary Syndromes |
| Ambrosio GB |
- |
Duration of Anticoagulant Treatment and Recurrence of Venous Thromboembolism in Patients with and without Thrombophilia |
| Amelot A |
- |
Thrombin-Activatable Factor X Re-establishes an Intrinsic Amplification in Tenase-deficient Plasmas |
| Amengual O |
- |
Determination of IgM Phosphatidylserine Dependent Antiprothrombin Antibodies Improves the Diagnostic Yield of Antiphospholipid Syndrome |
| Ames PRJ |
- |
Higher Warfarin Requirement in Anticoagulated Antiphospholipid Syndrome Patients to Acquire the Target INR |
| |
- |
Oxidative Modification of Low-density Lipoprotein (LDL) and OxLDL/b2GPI Complexes in Patients with Infectious Endocarditis: Possible Role in Aortic Valve Disease |
| Amighi J |
- |
Complement Component C5a Predicts Future Cardiovascular Events in Patients with Advanced Atherosclerosis |
| Amini SH |
- |
Study of Genetic Risk Factors for Cardiovascular Disease in the Iranian Population by Means of Reverse-Hybridization Teststrips |
| Amini-Bavil-Olyaee S |
- |
Carrier Detection and Prenatal Diagnosis of Two Short Tandem Repeats within Factor VIII Gene in Iranian Population |
| Amiral J |
- |
Binding of B2GP1 to Various Phospholipid Mixtures Is Calcium Dependent and Is Dramatically Enhanced by Antibodies: Understanding the Anticoagulant Paradox |
| |
- |
Antibodies to Phospholipid Cofactor Proteins Inhibit Their Binding to High Affinity Plps But Strongly Enhance Their Binding to Low Affinity Plps |
| |
- |
Measurement of Hirudin and Synthetic Thrombin Inhibitors in Plasma with a New Clotting Method, without Interference of Clotting Factor Levels |
| |
- |
A Novel, Specific and Quantitative Assay for Measuring Factor V-Leiden, with a Single Step Clotting Method |
| Amiral J |
- |
Increased Coagulation Activation in Persons with Echogenic Carotid Plaques |
| Amirkhosravi A |
- |
CD40 and CD40 Ligand (CD40L) in Primary Hemostasis and Antibody-Mediated Platelet Activation |
| Amirkhosravi A |
- |
Genetic Evidence that CD154 (CD40 Ligand) Plays a Pathophysiologic Role in the Systemic Coagulopathy Associated with Murine Models of Experimental Metastasis and Endotoxemia |
| Amirkhosravi A |
- |
Experimental Metastasis and Tumor Cell-Induced Coagulopathy in Mice with Hemophilia A and the Effect of FVIII Replacement Therapy |
| |
- |
Cellular Effects of Heparin-PF4 Antibodies and Its Relevance to the Pathogenesis of Heparin-Induced Thrombocytopenia |
| |
- |
Platelet Microparticles (PMP) Are Increased in Patients with Localized Prostate Cancer and Correlate with Plasma Tissue Factor (TF) Antigen Levels |
| |
- |
Importance of Pre-Analytical Variables in the Measurement of Platelet-Derived Microparticles |
| Amlot N |
- |
Management of VTE in the Outpatient Setting: Findings from a UK Prospective Outpatient Treatment Registry (VERITY) |
| |
- |
Assessment of Suspected Venous Thromboembolism in the UK: Findings from a Prospective Outpatient Treatment Registry (VERITY) |
| |
- |
Venous Thromboembolism Occurs Commonly Out-Of-Hospital in Patients Recently Immobilized through Surgery or Illness: Findings from the VERITY Outpatient Treatment Registry |
| Ämmälä P |
- |
Antithrombotic Treatment in Patients with Recurrent Miscarriage |
| Ammar S |
- |
Antiphospholipid Syndrome and Risk of Myocardial Infarction in Young: A Preliminary Study |
| Amore C |
- |
Inhibition of the Renin-Angiotensin System Modulates the Procoagulant/Fibrinolytic Potential of Human Breast Carcinoma Cells |
| |
- |
Effect of Paclitaxel on the Coagulation/Fibrinolytic System Pattern in Cancer and Host's Tumor-Associated Cells |
| Ampaiwan C |
- |
Coagulation Defects in Thai Adolescents with Menorrhagia |
| |
- |
Homocysteine and Thrombosis in Thai Children: A Case-Control Study |
| Ampaiwan C |
- |
Vitamin K Status in Mothers and Their Newborn Babies: Role of Dietary Phylloquinone Intake |
| An MO |
- |
Contribution of Thymidylate Synthase Enhancer Region (TSER) Polymorphism to Total Plasma Homocysteine Levels in Korean Patients with Recurrent Spontaneous Abortion |
| An SSA |
- |
Possible Interactions between Prion Protein and Transglutaminase: Irreversible Cross-Linking of Prion Protein to Fibrinogen by Factor XIIIa |
| An S |
- |
A Novel Fibrinogen Variant (Fibrinogen Seoul II: AaGln328Pro) with Impaired Fibrin Aa-chain Cross-linking |
| Anagnostopoulos A |
- |
Congenital Prothrombotic Disorders in Children with Venous and Arterial Thrombosis |
| Anannit V |
- |
Homocysteine and Thrombosis in Thai Children: A Case-Control Study |
| Ananyeva N |
- |
The A2 Domain of Coagulation Factor VIII Shares Residues Critical for Interaction with Three Members of LDL Receptor Superfamily – LRP, VLDL and Megalin Receptors |
| Ananyeva NM |
- |
Two Subpopulations of Activated Platelets Differ in Their Binding of the Components of the Intrinsic fX-Activating Complex |
| |
- |
Factor VIIIa Regulates Substrate Delivery to the Intrinsic Factor X-Activating Complex |
| Ananyeva N |
- |
Identification of Coagulation Factor VIII A2 Domain Residues Forming the Binding Epitope for Low-Density Lipoprotein Receptor-Related Protein |
| |
- |
Receptor-mediated Catabolism and Clearance of Factor VIII |
| Anastasio R |
- |
Objective Assessment of Pulmonary Embolism Can Be Deferred without Risk |
| |
- |
Residual Vein Thrombosis Assessment Establishes the Optimal Duration of Oral Anticoagulants in Patients with Idiopathic or Provoked Deep Vein Thrombosis: a Randomized, Controlled Trial |
| |
- |
Thrombophilia in Women with Unexplained Fetal Loss |
| |
- |
Successful Treatment of Acquired Haemophilia with FEIBA® and Retuximab® |
| Anastasio R |
- |
Thrombophilia in Young Adults with Ischemic Stroke Not Related to Cardiovascular Risk Factors |
| Anastasopoulou I |
- |
CoaguChek S Accuracy And Reproducibility in Comparison with the BCS Analyzer: Results in an Outpatient Anticoagulation Clinic |
| |
- |
The Use Of ROTEM for the Evaluation of Effectiveness of Recombinant FVIIa Administration in Patients with Uncontrollable Bleeding |
| |
- |
Population Pharmacokinetics of the ReFacto® Factor VIII for Prophylactic Treatment of HIV- and HIV+ Individuals with Haemophilia A |
| Ancona E |
- |
Long-Term Treatment with High-Dose Recombinant Human Antithrombin does not Prevent Acute Humoral Rejection in Primate Recipients of Porcine Xenografts |
| Ancora MA |
- |
Homocysteine (Hcy) Stimulates Endothelial Vascular Cell Adhesion Molecule(VCAM)-1 Via Nuclear Factor(NF)-kB Activation Induced by an Increase of Reactive Oxygen Species (ROS): Protective Role by Natural Antioxidants |
| Andersen O |
- |
The A2 Domain of Coagulation Factor VIII Shares Residues Critical for Interaction with Three Members of LDL Receptor Superfamily – LRP, VLDL and Megalin Receptors |
| Andersen L |
- |
Visualization of Dynamic Fibrin Formation from APTT Recordings Reflects More Heterogeneity in Patients with Severe Haemophilia A Than Conventional APTT Values |
| Andersen CB |
- |
Uremia-specific Effect on the Arterial Media during Development of Uremic Atherosclerosis in apolipoprotein-E Deficient Mice |
| Andersen TO |
- |
Dose-Dependent And Differential Effects of Two Doses of Continuous Combined Hormone Replacement Therapy (HRT), Tibolone And Raloxifene on Markers of Coagulation Activation |
| Andersen MD |
- |
Activation Hypothesis for Coagulation Factor VIIa |
| Andersen L |
- |
Visualization of the Continuous APTT Coagulation Signature – Methods and Correlations to Continuous Thrombin Generation |
| Andersen O |
- |
Identification of Regions in Low-Density Lipoprotein Receptor-Related Protein Responsible for Interaction with A2 and A1/A3-C1-C2 Portions of Coagulation Factor VIII |
| Andersen JC |
- |
Successful Management of Pregnancy in a Patient with Type III Von Willebrand Disease and Platelet Storage Pool Disorder |
| Anderson FA |
- |
The Influence of Previous or Currently Active Cancer on Venous Thromboembolism Prophylaxis Prescribing Practices in Acutely Ill Medical Patients |
| Anderson PJ |
- |
Synergistic Effects of Zinc and Calcium Ions on ADAMTS13 Proteolysis of Von Willebrand Factor and FRETS-VWF73 |
| Anderson PJ |
- |
Platelet-VWF Complexes Are Preferred Substrates of ADAMTS13 Under Shear Stress |
| Anderson S |
- |
A Novel Cytokine Mediated Route of Promoting the Adhesion of Platelets to Endothelial Cell Monolayers |
| Anderson Jr FA |
- |
Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: Do Perceived Risk Factors for Bleeding Influence Physicians' Practices? Findings From the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) |
| |
- |
Effect of Blood Salvage and Re-infusion on VTE Complications in Patients Undergoing Elective Major Orthopedic Surgery |
| |
- |
Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients in Intensive Care Units |
| Anderson Jr FA |
- |
Observed Rates of Clinically Apparent Venous Thromboembolism and Death Due to Pulmonary Embolism Among Unselected Hospitalized Acutely Ill Medical Patients Compared to Rates Predicted from Clinical Trials |
| Anderson Jr. FA |
- |
Does Body Weight Influence Physician Practices for Providing Venous Thromboembolism Prophylaxis to Acutely Ill Medical Patients? Findings from IMPROVE |
| Anderson, Jr FA |
- |
Physician Practices for Providing Venous Thromboembolism Prophylaxis to Hospitalized Acutely Ill Medical Patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) |
| Andersson E |
- |
Role of the Thrombin Receptor (PAR-1) in the Regulation of Menstrual Bleeding |
| Andersson M |
- |
ASA and NSAIDs with Melagatran/Ximelagatran or Enoxaparin Do NOT Increase Bleeding in Patients Undergoing Joint Replacement Surgery. The METHRO III Study |
| Andersson S |
- |
Patient Preference and Willingness-To-Pay Among Different Oral Anticoagulant Treatment Options |
| Andersson M |
- |
A Chromogenic Method with High Resolution for Determination of Human FIX Activity in Purified Preparations |
| |
- |
Fibrinolytic Gene Polymorphism and Ischemic Stroke |
| Andrade LEC |
- |
Anticardiolipin Antibodies (ACL), Factor V Leiden (FVL) and G20210A Prothrombin Mutation (G20210AII) Do Not Predispose Renal Transplant Recipients to Thrombotic Complications or Graft Loss |
| Andrade M |
- |
Expression of TFPIb in Normal Human Tissues and Inhibitory Activity on Tissue Factor-Initiated Coagulation Reactions by Recombinant TFPIb from Transfected CHO Cells and Escherichia Coli |
| Andrade LEC |
- |
The Behavior of Anticardiolipin Antibodies Levels in Patients with Venous Thromboembolism |
| Andrade Ferreira I |
- |
Inhibition of Collagen-Induced Thrombus Formation by Insulin Is Absent in Diabetes Mellitus Type 2 |
| |
- |
Glucose Uptake Via GLUT3 in Human Platelets Is Regulated Via PKB |
| |
- |
Impaired Insulin Signaling in Platelets from Patients with Diabetes Mellitus Type 2 |
| Andre P |
- |
Reduction of Ex Vivo Thrombus Evolution with Anti-Platelet Therapy during Percutaneous Coronary Intervention: The REVEAL Study |
| Andrea L |
- |
Neonatal Gene Therapy with Lentiviral Vector in Murine Hemophilia a Results in Successful Immune Tolerance Induction to Canine Factor VIII |
| Andreenko G |
- |
Endotheliumdependent Factors of Haemostasis and Fibrinolysis in Some Renal Diseases |
| Andree |
